Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
sodium sulfate, potassium sulfate, and magnesium sulfate for oral solution
Overview
What is ColPrep Kit?
ColPrep Kit (sodium sulfate, potassium sulfate and magnesium sulfate) for oral solution is an osmotic laxative that includes two 200 mL bottles and one 20-ounce mixing container. Each bottle contains 22.7 g of white to off-white granular powder including sodium sulfate 17.5 g, potassium sulfate 3.13 g, and magnesium sulfate 1.6 g and the following inactive ingredients: citric acid anhydrous, sucralose, and lemon flavor.
What does ColPrep Kit look like?






What are the available doses of ColPrep Kit?
For oral solution: Two bottles per ColPrep Kit. Each bottle contains sodium sulfate 17.5 g, potassium sulfate 3.13 g, and magnesium sulfate 1.6 g.
What should I talk to my health care provider before I take ColPrep Kit?
How should I use ColPrep Kit?
ColPrep Kit is indicated for cleansing of the colon as a preparation for colonoscopy in adults.
The recommended dosage of ColPrep Kit is one bottle administered in the evening before colonoscopy and the second bottle administered the morning of colonoscopy as follows:Dose 1: Early in the evening prior to colonoscopy, 10 to 12 hours before the second dose.Dose 2: The morning of colonoscopy, at least 3 ½ hours before colonoscopy.
What interacts with ColPrep Kit?
Sorry No Records found
What are the warnings of ColPrep Kit?
Sorry No Records found
What are the precautions of ColPrep Kit?
Sorry No Records found
What are the side effects of ColPrep Kit?
Sorry No records found
What should I look out for while using ColPrep Kit?
Gastrointestinal obstruction. (, )
Bowel perforation. (, )
Gastric retention. ()
Ileus. ()
Toxic colitis or toxic megacolon. ()
Known allergies to components of the kit. (, )
What might happen if I take too much ColPrep Kit?
Sorry No Records found
How should I store and handle ColPrep Kit?
How Supplied:ColPrep Kit NDC 10702-283-23Storage:Keep out of reach of children.How Supplied:ColPrep Kit NDC 10702-283-23Storage:Keep out of reach of children.How Supplied:ColPrep Kit NDC 10702-283-23Storage:Keep out of reach of children.How Supplied:ColPrep Kit NDC 10702-283-23Storage:Keep out of reach of children.
Clinical Information
Chemical Structure
No Image foundClinical Pharmacology
Sulfate salts provide sulfate anions, which are poorly absorbed. The osmotic effect of unabsorbed sulfate anions and the associated cations causes water to be retained within the gastrointestinal tract.
Non-Clinical Toxicology
Gastrointestinal obstruction. (, )Bowel perforation. (, )
Gastric retention. ()
Ileus. ()
Toxic colitis or toxic megacolon. ()
Known allergies to components of the kit. (, )
Reactivity to the test may be depressed or suppressed in persons who are receiving corticosteroids or immunosuppressive agents. (8)
Reactivity to TUBERSOL may be temporarily depressed by certain live virus vaccines (measles, mumps, rubella, oral polio, yellow fever, and varicella). If a parenteral live attenuated virus vaccine has been administered recently, tuberculin testing should be delayed for >1 month after vaccination. (8) (12) (See .)
When tuberculin screening is required at the same time as a measles-containing vaccine or other parenteral live attenuated virus vaccine, simultaneous administration of TUBERSOL and the vaccine at separate sites is the preferred option.
Advise all patients to hydrate adequately before, during, and after the use of ColPrep Kit. If a patient develops significant vomiting or signs of dehydration after taking ColPrep Kit, consider performing post-colonoscopy lab tests (electrolytes, creatinine, and BUN). Fluid and electrolyte disturbances can lead to serious adverse events including cardiac arrhythmias, seizures and renal impairment.
Patients with electrolyte abnormalities should have them corrected before treatment with ColPrep Kit. In addition, use caution when prescribing ColPrep Kit for patients with conditions, or who are using medications, that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and renal impairment.
ColPrep Kit can cause temporary elevations in uric acid. . Uric acid fluctuations in patients with gout may precipitate an acute flare. The potential for uric acid elevation should be considered before administering ColPrep Kit to patients with gout or other disorders of uric acid metabolism.
Reference
This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"
While we update our database periodically, we cannot guarantee it is always updated to the latest version.
Review
Professional
Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72Tips
Tips
Interactions
Interactions
A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).